Guardant Health
GH
#1177
Rank
NZ$34.27 B
Marketcap
NZ$258.45
Share price
-1.22%
Change (1 day)
239.77%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): NZ-$5.79

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.82. In 2025 the company made an earnings per share (EPS) of NZ-$5.69 an increase over its 2024 EPS that were of NZ-$6.12.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.791.88%
2025NZ-$5.69-7.02%
2024NZ-$6.12-16.82%
2023NZ-$7.35-33.13%
2022NZ-$11.0060%
2021NZ-$6.8755.04%
2020NZ-$4.43207.14%
2019NZ-$1.44-19.81%
2018NZ-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$4.82-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$4.26-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA